Constitutional epimutation as a mechanism for cancer causality and heritability?

PubWeight™: 0.92‹?›

🔗 View Article (PMID 26383139)

Published in Nat Rev Cancer on September 18, 2015

Authors

Megan P Hitchins1

Author Affiliations

1: Department of Medicine (Oncology), Stanford Cancer Institute, Stanford University, Grant Building S169, 1291 Welch Road, Stanford, California 94305, USA.

Articles cited by this

(truncated to the top 100)

The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05

Personal genomes: The case of the missing heritability. Nature (2008) 19.56

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12

Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet (2010) 14.81

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63

CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45

Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (1983) 9.28

Epigenetic inheritance at the agouti locus in the mouse. Nat Genet (1999) 9.14

Increased methylation variation in epigenetic domains across cancer types. Nat Genet (2011) 8.92

Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res (1997) 8.88

Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A (2008) 8.39

Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet (2008) 7.54

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85

Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science (2004) 6.35

Intra-individual change over time in DNA methylation with familial clustering. JAMA (2008) 6.17

Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02

Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol (2002) 5.86

An epigenetic mutation responsible for natural variation in floral symmetry. Nature (1999) 5.32

Epigenetic reprogramming in plant and animal development. Science (2010) 5.18

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res (1995) 5.11

The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer (2012) 4.97

Epigenetic inheritance and the missing heritability problem. Genetics (2009) 4.90

Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med (2007) 4.87

Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res (2011) 4.84

Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet (2004) 4.74

Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci U S A (2003) 4.70

A naturally occurring epigenetic mutation in a gene encoding an SBP-box transcription factor inhibits tomato fruit ripening. Nat Genet (2006) 4.59

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet (2008) 4.44

Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39

Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet (2002) 4.33

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28

The inheritance of epigenetic defects. Science (1987) 4.15

Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature (2010) 4.04

Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nat Genet (2011) 3.99

Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet (2002) 3.93

Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A (1998) 3.90

Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet (2006) 3.89

Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72

Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet (2003) 3.60

Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell (2007) 3.58

The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res (1983) 3.51

Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet (2004) 3.32

Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet (2004) 2.95

Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91

Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet (1994) 2.90

Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet (1989) 2.80

Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet (2002) 2.73

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A (1996) 2.63

Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet (2005) 2.62

Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell (2013) 2.56

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50

Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun (1983) 2.41

Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet (1994) 2.29

Transgenerational response to nutrition, early life circumstances and longevity. Eur J Hum Genet (2007) 2.27

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet (2008) 2.24

Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology (2003) 2.21

Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Phila) (2010) 2.08

A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res (2002) 2.07

Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res (2007) 2.02

Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J Natl Cancer Inst (2001) 2.02

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol (2010) 1.98

MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology (2005) 1.94

Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res (Phila) (2009) 1.78

Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet (1997) 1.70

DNA methylation contributes to natural human variation. Genome Res (2013) 1.66

Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol (2004) 1.64

Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) (2012) 1.61

Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. PLoS One (2008) 1.56

Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR. Cancer Cell (2011) 1.56

Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet (2000) 1.51

Longevity determined by paternal ancestors' nutrition during their slow growth period. Acta Biotheor (2001) 1.51

Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet (2008) 1.47

Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer (2015) 1.33

Transgenerational epigenetic inheritance: how important is it? Nat Rev Genet (2013) 1.32

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res (2008) 1.30

Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming. Genome Biol (2015) 1.30

Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLoS One (2012) 1.28

Epimutations and cancer predisposition: importance and mechanisms. Curr Opin Genet Dev (2010) 1.20

Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem Biophys Res Commun (2003) 1.19

Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. J Med Genet (2011) 1.15

Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet (2009) 1.13

Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet (2008) 1.13

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet (2009) 1.11

Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. Mod Pathol (2010) 1.11

MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Mod Pathol (2009) 1.10

Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat (2011) 1.07

Linkage of DNA methylation quantitative trait loci to human cancer risk. Cell Rep (2014) 1.07

Pesticide methoxychlor promotes the epigenetic transgenerational inheritance of adult-onset disease through the female germline. PLoS One (2014) 1.05

Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance. Nat Genet (2007) 1.04

Chromatin signature of widespread monoallelic expression. Elife (2013) 1.03

Environment-sensitive epigenetics and the heritability of complex diseases. Genetics (2011) 1.03

De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one. Int J Cancer (2011) 1.02

Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. Hum Reprod (2012) 1.02

Epimutations in human disease. Curr Top Microbiol Immunol (2006) 1.01

Transgenerational effects of betel-quid chewing on the development of the metabolic syndrome in the Keelung Community-based Integrated Screening Program. Am J Clin Nutr (2006) 0.97

Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion. Am J Gastroenterol (2011) 0.97

Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer. Epigenetics (2012) 0.95

Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Virchows Arch (2008) 0.94

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide. Neuro Oncol (2015) 0.93

Articles by these authors

Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer (2015) 1.33